Yahoo Suche Web Suche

Suchergebnisse

  1. Suchergebnisse:
  1. Vor 5 Tagen · Özlem Türeci, co-founder and chief medical officer at BioNTech, will present the latest research on mRNA vaccines. mRNA vaccines have gotten a lot of attention during the pandemic. Biotechnology company BioNTech developed the first messenger mRNA-based vaccine approved for use against covid-19.

  2. www.forbes.com › profile › ugur-sahinUgur Sahin - Forbes

    Vor einem Tag · In 2001 Şahin and his immunologist wife, ?zlem T'reci, cofounded Ganymed Pharmaceuticals; Astellas Pharma acquired Ganymed in 2016 for $460 million. Şahin and his wife T'reci cofounded BioNTech in...

  3. Vor 6 Tagen · El Círculo de Economía entrega su premio a la construcción europea a Uğur Şahin y Özlem Türeci, cofundadores de BioNtech. Los científicos lideraron la creación de la primera vacuna específica contra la Covid-19 durante la pandemia.

  4. Vor 6 Tagen · Özlem Türeci ve Uğur Şahin'den korkutan açıklama. Prof. Dr. Uğur Şahin'den flaş Delta ve 3. doz aşı açıklaması. Prof. Dr. Uğur Şahin haberi sayfasında en son yaşanan Prof. Dr. Uğur Şahin gelişmeleri ile birlikte geçmişten bugüne CNN Türk'e eklenen Prof. Dr. Uğur Şahin haber başlıkları yer almaktadır.

  5. Vor 5 Tagen · Oncolytics Biotech Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today announced it has presented two abstracts at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting.

  6. Vor 6 Tagen · Oncolytics Biotech Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today announced it has presented two abstracts at the 2024 American...

  7. Vor 6 Tagen · Oncolytics Biotech Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today announced it has presented two abstracts at the 2024 American...